Application

Trademark

Trademark/Service Mark Application, Principal Register

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 90112581
Filing Date: 08/13/2020

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 90112581
MARK INFORMATION
*MARK NOVORIG
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT NOVORIG
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Rapid Novor Inc.
*MAILING ADDRESS 137 Glasgow St., Unit 450
*CITY Kitchener, Ontario
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY Canada
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
N2G4X8
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION Canada
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS  
*IDENTIFICATION Proteomics analysis test kits comprising reagents for detecting, quantifying and characterizing antibody proteins in a biological sample for scientific research purposes; Medical diagnostic assay kits comprised of medical diagnostic reagents and assays for detecting cancer, autoimmune diseases and infections; Development of new technology for others in the field of biotechnology; Proteomics analysis services; Antibody profiling for scientific research purposes; Laboratory research in the field of immune sequencing; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of immune sequencing; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals; Research and analysis in the field of medicine; Research and development in the pharmaceutical and biotechnology fields; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Medical laboratory services; Providing medical diagnostic and prognostic testing for cancer, autoimmune diseases and infections, and the analysis, evaluation, and reporting of test results to help healthcare professionals determine a patient's clinical diagnosis, the effectiveness of treatments, and to revise future treatments accordingly; providing medical diagnostic and prognostic testing services; consulting services in the field of medical diagnostic testing; medical analysis services for diagnostic and treatment purposes provided by medical laboratories
FILING BASIS SECTION 44(d)
       FOREIGN APPLICATION NUMBER 2045788
       FOREIGN APPLICATION
       COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
Canada
       FOREIGN FILING DATE 08/13/2020
       INTENT TO
       PERFECT 44(d)
At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
CORRESPONDENCE INFORMATION
NAME Rapid Novor Inc.
DOCKET/REFERENCE NUMBER 0253429.0002
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE agalloway@millerthomson.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) daschnurr@millerthomson.com
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 1
APPLICATION FOR REGISTRATION PER CLASS 275
*TOTAL FEES DUE 275
*TOTAL FEES PAID 275
SIGNATURE INFORMATION
SIGNATURE /DAVIDSCHNURR/
SIGNATORY'S NAME David Schnurr
SIGNATORY'S POSITION Authorized Canadian Attorney
SIGNATORY'S PHONE NUMBER +1-
DATE SIGNED 08/13/2020



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)


Trademark/Service Mark Application, Principal Register

Serial Number: 90112581
Filing Date: 08/13/2020

To the Commissioner for Trademarks:

MARK: NOVORIG (Standard Characters, see mark)
The literal element of the mark consists of NOVORIG. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Rapid Novor Inc., a corporation of Canada, having an address of
      137 Glasgow St., Unit 450
      Kitchener, Ontario N2G4X8
      Canada
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class _______: Proteomics analysis test kits comprising reagents for detecting, quantifying and characterizing antibody proteins in a biological sample for scientific research purposes; Medical diagnostic assay kits comprised of medical diagnostic reagents and assays for detecting cancer, autoimmune diseases and infections; Development of new technology for others in the field of biotechnology; Proteomics analysis services; Antibody profiling for scientific research purposes; Laboratory research in the field of immune sequencing; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of immune sequencing; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals; Research and analysis in the field of medicine; Research and development in the pharmaceutical and biotechnology fields; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Medical laboratory services; Providing medical diagnostic and prognostic testing for cancer, autoimmune diseases and infections, and the analysis, evaluation, and reporting of test results to help healthcare professionals determine a patient's clinical diagnosis, the effectiveness of treatments, and to revise future treatments accordingly; providing medical diagnostic and prognostic testing services; consulting services in the field of medical diagnostic testing; medical analysis services for diagnostic and treatment purposes provided by medical laboratories

Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of priority based on Canada application number 2045788, filed 08/13/2020.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.



The applicant's current Correspondence Information:
      Rapid Novor Inc.
       PRIMARY EMAIL FOR CORRESPONDENCE: agalloway@millerthomson.com
       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): daschnurr@millerthomson.com
The docket/reference number is 0253429.0002.

Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $275 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: /DAVIDSCHNURR/   Date: 08/13/2020
Signatory's Name: David Schnurr
Signatory's Position: Authorized Canadian Attorney
Payment Sale Number: 90112581
Payment Accounting Date: 08/13/2020

Serial Number: 90112581
Internet Transmission Date: Thu Aug 13 16:42:45 ET 2020
TEAS Stamp: USPTO/BAS-XX.X.XXX.XX-202008131642453086
36-90112581-740a014aa213cb4ff7a3b5d99b7d
b5eae1f5942d958e88dd6e6395caf73da7e7-CC-
42438883-20200813163843274050

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed